As the Medical Device Manufacturers Association (MDMA) continues to take the lead in representing the interest of medtech companies, we wanted to sit down and talk with president and CEO, and Fogarty Institute board member, Mark Leahey, about the current landscape. MDMA is an incredibly nimble and effective organization – just like its constituents – and has been a beacon during the COVID-19 crisis,
When you’ve weathered adversity and come through on the other side, you bring a new perspective that can be helpful to those encountering a similar challenge for the first time. That’s why we turned to Allan Will for some advice based on his strong track record of founding, running, building and selling medical device companies,
When he is not helping a patient, mentoring entrepreneurs at Stanford Biodesign, supporting the Fogarty Institute as a board member or assessing how to develop a new medical device, Fred St Goar, MD, is looking for ways to help improve the global health system. Through a lifetime of fascinating medical experiences, he is well-equipped to wear all those hats equally well.
If you want a snapshot of Deborah (Deb) Kilpatrick’s storied career, you need look no further than the numerous accolades she has amassed. As just a sampling, she has been named on lists such as MM&M’s Top 40 Healthcare Transformers, FierceMedicalDevices’ Top Women in Medical Devices, Business Insider’s Most Powerful Women Engineers,
Training the next generation of medtech leaders is a topic of vital importance to the Fogarty Institute, given all our efforts in that direction. That’s why Andrew Cleeland was honored to be interviewed on that topic, along with Paul Yock, co-founder and director of the Stanford Biodesign program, at the opening dinner of the Wilson Sonsini Goodrich &
Every industry needs a “voice” standing up for it, and the entrepreneurial sector of the medical device industry is fortunate to have Mark Leahey, president and CEO of the Medical Device Manufacturers Association (MDMA), as its advocate on Capitol Hill.
Mark has spearheaded MDMA since 2001, when the organization was just him,
Given his impressive track record for inventions and the boundless energy he exhibits at the age of 85, no one would be surprised if Dr. Fogarty announced he had created his very own fountain of youth.
This passionate innovator never ceases to inspire and motivate us with the critical role he continues to play at the Fogarty Institute – checking in with the entrepreneurs on a daily basis as he brainstorms ideas and encourages them to keep looking for better pathways to solve critical problems,
He almost needs no introduction, and yet, we would be remiss in not sharing a few of his finest traits: A contagious passion for our industry, an affinity for finding better solutions and an enthusiasm to share his insight and knowledge.
The strength of a board comes from the diverse experiences of its members, their passion for the mission and their ability to provide sage advice. Lewis (Lew) Wexler, MD, one of the Fogarty Institute’s inaugural members, joined the board as the organization’s mission and structure were still being formed and over the years has been a staunch ally and supporter of its educational approach.
Angela Macfarlane Brings Decades of Medtech Experience and Mentoring Acumen to Fogarty Institute Board
Some people’s careers are a straight path, while others are a winding road. The latter was the case for Angela Macfarlane. After all, not many people can say they started their career in the field of law as a judicial extern for the United States District Court,